(Q44356684)

2 December 2017

Statins and the risk of pneumonia: a population-based, nested case-control study (English)

1 reference

2 December 2017

Susan S Jick

3

0 references

Hershel Jick

object named as

Hershel Jick

series ordinal

4

0 references

David S. Fedson

series ordinal

2

object named as

David S Fedson

1 reference

2 December 2017

Raymond G Schlienger

1

1 reference

PubMed ID

17316144

2 December 2017

Christoph R Meier

series ordinal

5

1 reference

PubMed ID

17316144

2 December 2017

language of work or name

English

0 references

publication date

1 March 2007

1 reference

2 December 2017

1 reference

2 December 2017

27

1 reference

2 December 2017

3

1 reference

2 December 2017

325-332

1 reference

Anti-inflammatory effects of statins: clinical evidence and basic mechanisms

2 December 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

In vitro effect of statins on cytokine production and mitogen response of human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

Simvastatin inhibits interleukin-6 release in human monocytes stimulated by C-reactive protein and lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

Monocyte release of tumor necrosis factor-alpha and interleukin-1beta in primary type IIa and IIb dyslipidemic patients treated with statins or fibrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

Effects of combined administration of low dose atorvastatin and vitamin E on inflammatory markers and endothelial function in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

Statin treatment after onset of sepsis in a murine model improves survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

The effect of statins on mortality in patients with bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

Use of the UK General Practice Research Database for pharmacoepidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

Validity of the General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

HMG-CoA reductase inhibitors and the risk of fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

Statin use and cancer risk in the General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

Risk of cataract in patients treated with statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

Statin treatment and reduced risk of pneumonia in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

Potential therapeutic role for statins in respiratory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

Cytokine-mediated inflammation in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

Pulmonary endothelium in acute lung injury: from basic science to the critically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

Pandemic influenza: a potential role for statins in treatment and prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

Avian influenza A (H5N1) infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

Preparing for pandemic vaccination: an international policy agenda for vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

Statin use and mortality within 180 days after bacteremia: A population-based cohort study*

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.3.325

21 January 2018

Identifiers

DOI

10.1592/PHCO.27.3.325

1 reference

2 December 2017

1 reference

PubMed ID

17316144